reports
- Maria Vara
- Oscar Haffen Lamm
End of coverage
From 5th February, we will no longer include in our research universe:Adaptimmune, ALK, argenx, Autolus, Cellectis, Galapagos, Hansa Biopharma, Heidelberg Pharma, Immatics, Immunocore, Ipsen, Moonlake Immunotherapeutics, Pharvaris, UCB, Vivoryon Therapeutics, Zealand Pharma, Nicox, GenSight Biologi
CLLS CELLECTIS ADS
ADAP ADAPTIMMUNE THERAPEUTICS ADS
ANZ AUSTRALIA AND NEW ZEALAND BANKING GROUP LIMITED
HPHA HEIDELBERG PHARMA AG
COX NICOX SA
UCB UCB S.A.
HNSA HANSA BIOPHARMA AB
SIGHT GENSIGHT BIOLOGICS SA
ALSEN SENSORION SAS
ALKb ALK-ABELLO
ARGX ARGEN-X SE
AUTL AUTOLUS THERAPEUTICS ADS
IMCR IMMUNOCORE HOLDINGS ADS
PHVS PHARVARIS NV
MLTX MOONLAKE IMMUNOTHERAPEUTICS
IMTX IMMATICS
GLG GALAPAGOS
VVY VIVORYON THERAPEUTICS
- Alex Cogut
Coverage update
Given team and strategy changes, Alex Cogut is now assuming coverage of Achilles Therapeutics, Adaptimmune Therapeutics, Autolus, Calliditas, Cellectis, Galapagos, GenSight, Hansa Biopharma, Heidelberg Pharma, Immunocore, Innate Pharma, Sesorion and ValerioWe drop coverage of Celyad Oncology BioNte
CLLS CELLECTIS ADS
ADAP ADAPTIMMUNE THERAPEUTICS ADS
TNG TRANSGENE SA
IPH INNATE PHARMA SA CLASS A
CYAD CELYAD ONCOLOGY
HNSA HANSA BIOPHARMA AB
SIGHT GENSIGHT BIOLOGICS SA
5142 ACHILLES CORP.
POXEL POXEL SA
BCART BIOCARTIS GROUP NV
CRSP CRISPR THERAPEUTICS AG
GNMSY GENMAB A/S
BNTX BIONTECH SE
CALTX CALLIDITAS THERAPEUTICS AB
IMCR IMMUNOCORE HOLDINGS ADS
IMTX IMMATICS
GLG GALAPAGOS
- Ingird Gafanhão
- Oscar Haffen Lamm
Conference updates: takeaways from ASCO and ISCT
We wrap up the past conference-filled weeks with a summary of the main takeaways from our coverage. From the International Society for Cell & Gene Therapy (ISCT) meeting, we point out i) Cellectis preclinical updates, and ii) a KOL dinner we hosted with Dr Bruce Levine discussing how to improve
- Maria Vara
- Ingird Gafanhão
Reports Q1 2023 results, stops UCARTCS1 trial
Cellectis reported Q1 2023 results, with revenues of USD 3.6m (USD 3.8m), reflecting the recognition of USD 1.5m in milestones related to Cellectis’ agreement with Cytovia, R&D expenses of USD 21.1m (USD 26.6m), and SG&A expenses of USD 5.0 m (USD 6.1m). The company reported a decreased net
- Dave Nicoski
- Ross LaDuke
Vermilion Short Shots: Technically Vulnerable Stocks
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SEDG SOLAREDGE TECHNOLOGIES INC.
RUN SUNRUN INC.
PTCT PTC THERAPEUTICS INC.
NSY NICE SYSTEMS LTD (ADR)
JD JD.COM INC. SPONSORED ADR CLASS A
EBS EMERGENT BIOSOLUTIONS INC.
CLLS CELLECTIS ADS
FF FUTUREFUEL CORP.
ADNu ACADIAN TIMBER CORP
ODEL.N0000 ODEL PLC
PAGS PAGSEGURO DIGITAL LTD
YMAB Y-MABS THERAPEUTICS
TPTX TURNING POINT THERAPEUTICS
FSLY FASTLY
RPAY REPAY HOLDINGS (A)
IGMS IGM BIOSCIENCES
PTON PELOTON INTERACTIVE INC. CLASS A
PNTG PENNANT GROUP
GLT GLATFELTER CORPORATION
SPCE VIRGIN GALACTIC HOLDINGS (A)
RIDE LORDSTOWN MOTORS CORP (A)
HYLN HYLIION HOLDINGS CORP (A)
APPH APPHARVEST INC
FMTX FORMA THERAPEUTICS HOLDINGS
VIEW VIEW INC
- Dave Nicoski
- Ross LaDuke
VYGR VOYAGER THERAPEUTICS INC.
V VISA INC. CLASS A
SPWH SPORTMANS WAREHOUSE HOLDINGS
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SGMO SANGAMO THERAPEUTICS INC.
SEDG SOLAREDGE TECHNOLOGIES INC.
ROK ROCKWELL AUTOMATION INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PRLB PROTO LABS INC.
NVMI NOVA MEASURING INSTRUMENTS LTD
NVDA NVIDIA CORPORATION
NBIX NEUROCRINE BIOSCIENCES INC.
MTH MERITAGE HOMES CORPORATION
LHCG LHC GROUP INC.
JD JD.COM INC. SPONSORED ADR CLASS A
IPHI INPHI CORPORATION
IPGP IPG PHOTONICS CORPORATION
GWPH GW PHARMACEUTICALS PLC SPONSORED ADR
DVAX DYNAVAX TECHNOLOGIES CORPORATION
CREE CREE INC.
CORT CORCEPT THERAPEUTICS INCORPORATED.
CLLS CELLECTIS ADS
CIEN CIENA CORPORATION
CGNX COGNEX CORPORATION
CDE COEUR MINING INC.
CAMT CAMTEK LTD.
BIG BIG LOTS INC.
BBY BEST BUY CO. INC.
AAWW ATLAS AIR WORLDWIDE HOLDINGS INC.
MAS MASCO CORPORATION
IRBT IROBOT CORPORATION
MAG. MAG SILVER CORP.
PSNTF AURORA CANNABIS INC.
FR. FIRST MAJESTIC SILVER CORP.
FVI. FORTUNA SILVER MINES INC.
PAAS PAN AMERICAN SILVER CORP.
SIL SILVERCREST METALS
ENPH ENPHASE ENERGY INC.
GNRC GENERAC HOLDINGS INC.
MBUU MALIBU BOATS INC. CLASS A
SAM BOSTON BEER COMPANY INC. CLASS A
CWH CAMPING WORLD HOLDINGS INC. CLASS A
NTLA INTELLIA THERAPEUTICS INC.
CYRX CRYOPORT INC.
CRSP CRISPR THERAPEUTICS AG
ZTO ZTO EXPRESS (CAYMAN) INC. SPONSORED ADR CLASS A
BHP BHP GROUP
ASML ASML HOLDING N.V.
MDGL MADRIGAL PHARMACEUTICALS
SPGI S&P GLOBAL INC.
ARGX ARGENX ADS
VICR VICOR CORP.
LQDA LIQUIDIA CORPORATION
PDD PINDUODUO INC. SPONSORED ADR CLASS A
TBIO TRANSLATE BIO
SWAV SHOCKWAVE MEDICAL
RPAY REPAY HOLDINGS (A)
ATEX ANTERIX INC
MMX MAVERIX METALS
ARCT ARCTURUS THERAPEUTICS HOLDINGS INC
GRWG GROWGENERATION
ADPT ADAPTIVE BIOTECHNOLOGIES CORP.
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Round Trip Back To Resistance Our base case continues to be for near-term consolidation while the market determines the implications of states' reopening (i.e., the “wait-and-see†phase). Until this consolidation period resolves below support or above resistance we are maintaining a relatively neutral stance considering the wide range of outcomes. Below we highlight new developments which remain generally positive. Still, many major indexes are testing logical resistance and until we see br...
NEWR NEW RELIC INC.
TMUS T-MOBILE US INC.
TWOU 2U INC.
SUPN SUPERNUS PHARMACEUTICALS INC.
SPWH SPORTMANS WAREHOUSE HOLDINGS
SAIA SAIA INC.
ROK ROCKWELL AUTOMATION INC.
PRLB PROTO LABS INC.
PFSW PFSWEB INC
PAYC PAYCOM SOFTWARE INC.
OLLI OLLIE'S BARGAIN OUTLET HOLDINGS INC
NVMI NOVA MEASURING INSTRUMENTS LTD
NEH NETEASE INC. SPONSORED ADR
NKTR NEKTAR THERAPEUTICS
NDSN NORDSON CORPORATION
NBIX NEUROCRINE BIOSCIENCES INC.
LOW LOWE'S COMPANIES INC.
KHC KRAFT HEINZ COMPANY
JD JD.COM INC. SPONSORED ADR CLASS A
HD HOME DEPOT INC.
GWPH GW PHARMACEUTICALS PLC SPONSORED ADR
GDOT GREEN DOT CORPORATION CLASS A
ECL ECOLAB INC.
EBS EMERGENT BIOSOLUTIONS INC.
COLL COLLEGIUM PHARMACEUTICAL INC.
CLLS CELLECTIS ADS
CIEN CIENA CORPORATION
CGNX COGNEX CORPORATION
CDNA CAREDX INC
CDE COEUR MINING INC.
CAMT CAMTEK LTD.
BIG BIG LOTS INC.
AU ANGLOGOLD ASHANTI LTD. ADS
AGIO AGIOS PHARMACEUTICALS INC.
ABMD ABIOMED INC.
MAS MASCO CORPORATION
IRBT IROBOT CORPORATION
MAG. MAG SILVER CORP.
FR. FIRST MAJESTIC SILVER CORP.
FVI. FORTUNA SILVER MINES INC.
SIL SILVERCREST METALS
CENT CENTRAL GARDEN & PET COMPANY
ENPH ENPHASE ENERGY INC.
GLOB GLOBANT SA
WERN WERNER ENTERPRISES INC.
FLWS 1-800-FLOWERS.COM CL A
CWH CAMPING WORLD HOLDINGS INC. CLASS A
NTLA INTELLIA THERAPEUTICS INC.
KNSL KINSALE CAPITAL GROUP INC.
CRSP CRISPR THERAPEUTICS AG
MDGL MADRIGAL PHARMACEUTICALS
SPGI S&P GLOBAL INC.
KALA KALA PHARMACEUTICALS INC.
BKI BLACK KNIGHT INC.
ANGI ANGI INC. CLASS A
ATOM ATOMERA
PS PLURALSIGHT (A)
BILI BILIBILI INC. SPONSORED ADR CLASS Z
TENB TENABLE HOLDINGS
REPL REPLIMUNE GROUP
RAMP LIVERAMP HOLDINGS INC.
TBIO TRANSLATE BIO
NGM NGM BIOPHARMACEUTICALS
TPTX TURNING POINT THERAPEUTICS
SWAV SHOCKWAVE MEDICAL
CVET COVETRUS
SCPL SCIPLAY
AMCR AMCOR PLC
RPAY REPAY HOLDINGS (A)
MMX MAVERIX METALS
NVAX NOVAVAX INC.
CRNC CERENCE
SPT SPROUT SOCIAL
PSNL INC.
ADPT PERSONALIS
AXNX ADAPTIVE BIOTECHNOLOGIES CORP.
OCFT AXONICS MODULATION TECH
CRL ONECONNECT FINANCIAL TECHNOLOGY CO. LTD.
CAREL INDUSTRIES SPA
INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Cellecti...
LOS ANGELES--(BUSINESS WIRE)-- Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cellectis S.A. (“Cellectis” or the “Company”) (Nasdaq: CLLS). If you purchased or otherwise acquired Cellectis shares, and would like more information about the investigation, we encourage you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars, Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your ri...
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investig...
NEW YORK--(BUSINESS WIRE)-- Levi & Korsinsky announces it has commenced an investigation of Cellectis S.A. (“Cellectis” or the “Company”) (NASDAQ: CLLS) concerning possible violations of federal securities laws. On September 5, 2017, Cellectis revealed that the U.S. Food and Drug Administration had suspended two of Cellectis’ early-stage studies for its experimental blood cancer treatment UCART123, following the death of a patient. Following this news, Cellectis stock has dropped as much as $10.18 per share, or 31.63%, during...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Inves...
NEW YORK--(BUSINESS WIRE)-- Levi & Korsinsky announces it has commenced an investigation of Cellectis S.A. (“Cellectis” or the “Company”) (NASDAQ:CLLS) concerning possible violations of federal securities laws. On September 5, 2017, Cellectis revealed that the U.S. Food and Drug Administration had suspended two of Cellectis’ early-stage studies for its experimental blood cancer treatment UCART123, following the death of a patient. Following this news, Cellectis stock has dropped as much as $10.18 per share, or 31.63%, during ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.